Back To TOP

Our Services My Patient Solutions™

My Patient Solutions

My Patient Solutions connects your office with ours. We’re available online to help you with access and reimbursement whenever a Genentech medicine is prescribed. It’s the most efficient way to work with Genentech Access Solutions to get your patients on therapy as soon as possible.


Features of My Patient Solutions

My Patient Solutions helps you manage patient access from enrollment to treatment.


Online enrollment

Prescriber electronic signatures and scanned document attachments allow for a completely paperless patient enrollment process.


Benefits investigation reports

Your patients’ full benefits investigation (BI) reports are uploaded to My Patient Solutions in real time so you can know exactly what is covered before beginning treatment.


Search your patient cases

Search for patient cases initiated via fax or through My Patient Solutions for easier patient case management.


Genentech® Access to Care Foundation (GATCF) refill requests

Request refills for GATCF prescriptions online via My Patient Solutions to avoid interruption in therapy.



Get alerts (eg, Statement of Medical Necessity form expiring in 30 days) to learn what actions you should take to connect your patients to their medicine. You can opt to receive these alerts via email as well.


Information you need to register your practice:

You will need the following information in order to successfully register your practice:

  1. Primary Genentech products prescribed by your practice
  2. User information including email addresses (you may add additional users at a later date)
  3. Practice location information (you may add additional locations at a later date)
  4. Prescriber licensing information:
    • Prescriber National Provider Identifier (NPI)
    • State license number (required)


You are then asked to agree to the My Patient Solutions Practice Agreement. You must agree to these terms to proceed with My Patient Solutions.

Learn More About
  • LEARN about treatment with Pulmozyme
  • FIND the right patient assistance program with our Compass for Patient Access tool
  • LEARN HOW the Pulmozyme Co-pay Card Program can help with the out-of-pocket costs for Pulmozyme
  • Download: new forms for enrollment in GATCF
  • Form Statement of Medical Necessity
  • Form Patient Authorization and Notice of Release of Information (Current Version)

Pulmozyme Indication and Important Safety Information


Daily administration of Pulmozyme Inhalation Solution in conjunction with standard therapies is indicated in the management of cystic fibrosis (CF) patients to improve pulmonary function. In patients with an FVC ≥40% of predicted, daily administration of Pulmozyme has also been shown to reduce the risk of respiratory tract infections requiring parenteral antibiotics. Safety and efficacy of daily administration have not been demonstrated in patients for longer than 12 months.


  • Pulmozyme is contraindicated in patients with known hypersensitivity to dornase alfa, Chinese hamster ovary cell products, or any component of the product
  • Pulmozyme should be used in conjunction with standard therapies for CF
  • Most common reported adverse events associated with the use of Pulmozyme include: voice alteration, pharyngitis, laryngitis, rash, chest pain, and conjunctivitis

You may report side effects to the FDA at (800) FDA-1088 or You may also report side effects to Genentech at (888) 835-2555.

Please see full prescribing information for Pulmozyme, including additional Important Safety Information.